Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry

Marta Cobo Marcos1,2, Rafael de la Espriella3, Jara Gayán Ordás4

  • 1Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda (IDIPHISA), Madrid, Spain.

Insights

Women with heart and kidney disease show higher rates of heart failure with preserved ejection fraction (HFpEF) and advanced chronic kidney disease (CKD). Men present more often with heart failure with reduced ejection fraction (HFrEF) and ischemic causes.

Area of Science:

  • Cardiology
  • Nephrology
  • Sex-Based Medicine

Background:

  • Sex-specific differences in heart failure (HF) and kidney disease (KD) are well-documented individually.
  • The distinct cardiorenal syndrome (CRS) phenotypes by sex remain underexplored in contemporary patient cohorts.

Purpose of the Study:

  • To investigate sex-related differences in cardiorenal syndrome (CRS) among outpatients with heart failure (HF).

Main Methods:

  • Analysis of the prospective, multicenter Cardiorenal Spanish registry (CARDIOREN).
  • Inclusion of 1107 chronic ambulatory HF patients, assessing estimated glomerular filtration rate (eGFR) and clinical characteristics.
  • Statistical analysis to determine odds ratios (OR) and confidence intervals (CI) for sex-specific differences in CRS phenotypes.

Main Results:

  • Women with kidney dysfunction showed higher odds of HF with preserved ejection fraction (HFpEF), valvular heart disease, anemia, advanced CKD, and congestion.
  • Men with cardiorenal disease had higher odds of HF with reduced ejection fraction (HFrEF), ischemic cardiomyopathy, hypertension, atrial fibrillation, and hyperkalemia.
  • Significant sex-related differences in cardiorenal phenotypes were observed in this HF cohort.

Conclusions:

  • Distinct cardiorenal phenotypes exist between sexes in patients with combined heart and kidney disease.
  • Women predominantly exhibit a cardiorenal phenotype characterized by advanced CKD, congestion, and HFpEF.
  • Men are more frequently associated with HFrEF, ischemic etiology, hypertension, hyperkalemia, and atrial fibrillation.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
472
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
432
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
536
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23